Control of T lymphocyte activation and IL-2 receptor expression by endogenously secreted lymphokines

J Immunol. 1994 Jun 15;152(12):5714-22.

Abstract

The relative contribution of endogenously secreted lymphokines, TNF-alpha and IL-2, to T cell activation has been studied. Interestingly, a neutralizing anti-TNF-alpha mAb strongly inhibited the proliferation, IL-2R alpha expression, and activation of the nuclear factor (NF)-kappa B induced on human purified T lymphocytes by an immobilized anti-CD3 mAb (imm.anti-CD3). Furthermore, the addition of exogenous TNF-alpha to T cells activated by imm.anti-CD3 or phorbol esters strongly stimulated all those activities. Similarly, neutralizing anti-IL-2R alpha Abs inhibited the cell proliferation and the IL-2R alpha expression induced by imm.anti-CD3, whereas exogenous addition of IL-2 enhanced both activities. However, exogenous addition of IL-2 did not affect NF-kappa B activation. Cyclosporin A, which prevented lymphokine mRNA transcription, inhibited more than 90% of the IL-2R alpha and NF-kappa B levels induced by TCR/CD3-mediated activation. Exogenous TNF-alpha and IL-2 were equally important to the partial recovery of this IL-2R alpha inhibition, and high doses of both lymphokines together completely abolished the inhibitory effect of cyclosporin A. However, only TNF-alpha (but not IL-2) efficiently recovered the nuclear NF-kappa B levels. Those results indicate that the autocrine secretion of TNF-alpha and IL-2, and not the primary stimulus itself, contribute mostly to the regulation of IL-2R; thereby playing a very important role in quantitative control of T cell proliferation and leaving to the specifically TCR/CD3-derived signals the triggering role in T cell activation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal / pharmacology
  • Base Sequence
  • CD3 Complex / metabolism
  • Cyclosporine / pharmacology
  • DNA / genetics
  • Humans
  • In Vitro Techniques
  • Interleukin-2 / metabolism*
  • Interleukin-2 / pharmacology
  • Lymphocyte Activation*
  • Molecular Sequence Data
  • NF-kappa B / metabolism
  • Receptors, Interleukin-2 / antagonists & inhibitors
  • Receptors, Interleukin-2 / genetics
  • Receptors, Interleukin-2 / metabolism
  • T-Lymphocytes / immunology*
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors
  • Tumor Necrosis Factor-alpha / metabolism
  • Tumor Necrosis Factor-alpha / pharmacology

Substances

  • Antibodies, Monoclonal
  • CD3 Complex
  • Interleukin-2
  • NF-kappa B
  • Receptors, Interleukin-2
  • Tumor Necrosis Factor-alpha
  • Cyclosporine
  • DNA